Grifols, S.A. (GRFS) Price Target Analysis

Analyst Rating: Buy

Based on 8 analysts

No Target Data

GRFS trades at Wall Street's consensus target of —.

Current Price$7.28

Average Target—

Low—

Median—

High—

Analyst Target Range

Forward P/E8.8x

(Value)

PEG Ratio—

Implied Growth+37.2%

(High Growth)

Analyst Spread—

Price Forecast (1 Year)

Last 12 months price action with 12-month analyst target path

Current$7.28

Consensus—

High—

Low—

Consensus Scenario Assumptions

The base valuation assumes GRFS achieves its forward estimates and maintains a stable P/E multiple of 8.8x. This scenario reflects the blended consensus of 8 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.

Analyst Ratings Distribution

Breakdown of 8 published analyst recommendations for GRFS

25% hold / mixed conviction

BearishBullish

Weighted analyst sentiment score based on 8 ratings

ConsensusBuy

Coverage8 Analysts

Net Score+13

Bull / Bear50% / 25%

Strong Buy00%

Buy450%

Hold225%

Sell225%

Strong Sell00%

Strong Buy

00%

Buy

450%

Hold

225%

Sell

225%

Strong Sell

00%

Recommendation Mix50% Buy · 25% Hold · 25% Sell

Buy (4)Hold (2)Sell (2)

GRFS Price Target Analysis

Updated June 23, 2026

As of June 23, 2026, Grifols, S.A. (GRFS) has a Wall Street consensus price target of N/A, based on estimates from 8 covering analysts. The company has a market capitalization of $6.16B.

Analyst price targets range from a low of N/A to a high of N/A.

The current analyst consensus rating is Buy, with 4 analysts rating the stock as a Buy or Strong Buy,2 rating it Hold, and 2 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.

From a valuation perspective, GRFS trades at a trailing P/E of 11.2x and forward P/E of 8.8x. Analysts expect EPS to grow +37.2% over the next year.

Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $5.79, with bear and bull scenarios of $3.65 and $7.62 respectively. Model confidence stands at 37/100, suggesting limited visibility into future performance.

Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.

Analyst Sentiment Comparison

Industry Peer Analysis

Avg Peer Upside

+53.2%

Industry Consensus

Avg Forward P/E

18.7x

(Fair)

Peers with Coverage

9 / 10

Active Analyst Tracking

Company	Market Cap	Price	Target	Upside Potential	Rating	Fwd P/E	Analysts
TAKTakeda Pharmaceutical Company Limited	$48.3B	$15.47	—	—	Buy	0.3x	6
CSLCarlisle Companies Incorporated	$14.8B	$360.96	$408.75	+13.2%	Buy	17.2x	26
BHVNBiohaven Ltd.	$1.6B	$15.50	$17.60	+29.7%	Buy	—	25
OCSLOaktree Specialty Lending Corporation	$1.0B	$11.42	$12.50	+7.9%	Hold	7.7x	12
BCRXBioCryst Pharmaceuticals, Inc.	$1.9B	$9.14	$16.86	+87.5%	Buy	—	29
RAREUltragenyx Pharmaceutical Inc.	$2.9B	$29.03	$48.36	+76.2%	Buy	—	33
AKROAkero Therapeutics, Inc.	$4.5B	$54.65	$48.40	-11.4%	Buy	—	14
ALNYAlnylam Pharmaceuticals, Inc.	$38.2B	$286.41	$454.27	+63.4%	Buy	37.1x	52
ARCTArcturus Therapeutics Holdings Inc.	$205M	$7.23	$22.50	+198.8%	Buy	—	21
BIOBio-Rad Laboratories, Inc.	$7.6B	$280.96	$321.67	+13.9%	Buy	31.2x	14

GRFS — Frequently Asked Questions

Quick answers to the most common questions about buying GRFS stock.

What is the GRFS stock price target for 2026?

The consensus price target for GRFS is $N/A, close to the current price of $7.28 (N/A% implied move). Based on 8 analyst estimates, the stock appears fairly valued near current levels.

Is GRFS a buy, sell, or hold?

GRFS has a consensus rating of "Buy" based on 8 Wall Street analysts. The rating breakdown is mixed, with 2 Hold ratings making up the largest segment. The consensus 12-month price target of $N/A implies N/A% upside from current levels.

Is GRFS stock overvalued or undervalued?

With a forward P/E of 8.8337x, GRFS trades at a relatively low valuation. The consensus target of $N/A implies N/A% appreciation, suggesting the market may be pricing in risks.

How high can GRFS stock go?

The most bullish Wall Street analyst has a price target of $N/A for GRFS, while the most conservative target is $N/A. The consensus of $N/A represents the median expectation. Our quantitative valuation model projects a bull case target of $8 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

How many analysts cover GRFS stock?

GRFS is moderately covered, with 8 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 2 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

What is the GRFS stock forecast?

The 12-month GRFS stock forecast based on 8 Wall Street analysts shows a consensus price target of $N/A, with estimates ranging from $N/A (bear case) to $N/A (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $6, with bear/bull scenarios of $4/$8.

What is GRFS's fair value based on fundamentals?

Our quantitative valuation model calculates GRFS's fair value at $6 (base case), with a bear case of $4 and bull case of $8. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 37/100.

What is GRFS's forward P/E ratio?

GRFS trades at a forward P/E ratio of 8.8x based on next-twelve-months earnings estimates compared to a trailing P/E of 11.2x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Should I buy GRFS stock?

GRFS appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $N/A target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

Why do GRFS price targets vary so much?

GRFS analyst price targets range from $N/A to $N/A, a NaN% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $N/A consensus represents the middle ground. Our model's $4-$8 range provides an independent fundamental perspective.

Consensus-Based Analysis Tools